{
    "nctId": "NCT02521623",
    "briefTitle": "SurgiMend\u00ae vs. Strattice\u2122 in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial",
    "officialTitle": "SurgiMend\u00ae vs. Strattice\u2122 in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 60,
    "primaryOutcomeMeasure": "Complication Rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient has been deemed eligible for an immediate breast reconstruction using implant and ADM by the responsible plastic and breast surgeon\n* Patient is older than 18 years of age\n* Patient understand enough Danish to comprehend the given information and to complete the study questionnaires\n\nExclusion Criteria:\n\n* Current smokers (patients not having paused for a minimum of four weeks prior to surgery)\n* Non-eligible patients, as assessed by operating surgeon\n* High level of co-morbidity, as assessed by operating surgeon or anesthesiologist",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}